Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02897362 · ClinicalTrials.gov registry record
Sleep Dysfunction and Neurocognitive Outcomes in Adolescent ADHD
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 62
- Enrollment target
NCT02897362: Completed study, sponsored by Duke University.
NCT02897362 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 62 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02897362 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 62 participants
- Enrollment target
Study Summary
This study seeks to characterize sleep physiology in adolescents with and without Attention deficit hyperactivity disorder (ADHD) and its relationship to differential neurocognitive and clinical outcomes within these groups.
Primary Outcome
Ambulatory polysomnographic measures of total sleep time, sleep onset latency, wake after sleep onset, and EEG spectral dynamics.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2016-08 |
| Est. Completion | 2021-07-01 |
What the finished NCT02897362 record still lists
NCT02897362 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 62 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02897362 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02897362 about?
NCT02897362 is a clinical study titled "Sleep Dysfunction and Neurocognitive Outcomes in Adolescent ADHD". This study seeks to characterize sleep physiology in adolescents with and without Attention deficit hyperactivity disorder (ADHD) and its relationship to differential neurocognitive and clinical outcomes within these groups.
What is the current status of trial NCT02897362?
This trial is currently completed. The enrollment target is 62 participants. The study started on 2016-08. Estimated completion is 2021-07-01.
Who is sponsoring clinical trial NCT02897362?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03231150 · 62 participants · NA
Plantar Fasciitis Randomized Clinical Control Trial
- NCT03458676 · 62 participants · NA
Radiologic Pathologic Correlation of Advanced MR Imaging to Guide the Biopsy of Cerebral Malignancies
- NCT03596086 · 62 participants · Phase 1
HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM
- NCT03603405 · 62 participants · Phase 1
HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia